32-1962. New drug; compliance with federal
act; exception


A. No person shall manufacture, sell, offer or hold for sale or give away any new
drug or device unless it fully complies with the provisions of the federal act.


B. This section shall not apply to the nutritional supplement amygdalin, a
cyano-genetic glycoside, also known as laetrile and vitamin B-17, which is processed from
the seeds of certain fruits including apricots, peaches and plums.